主题：【资料】“医疗用传感器器，生物传感器器与传感器系统”市场调查报告第二版（目录）

Table of Contents
•    Chapter One: Executive Summary
o    Market Definitions
o    Commercialization Challenges
o    Development Trends
o    Optical Biosensor Innovations
o    Microminiaturization of Sensors
o    Summary and Comparison of Results
•    Chapter Two: Introduction
o    Definitions and Categories
o    Classification of Sensors Based on Analyte
o    Classification by Measurement and Control
o    Classification by Element and Operation
o    Advantages of Biosensors
•    Chapter Three: Biosensor Technology
o    General Biosensor Technology
    Liquid Handling Systems
    Signal Processing and Data Analysis
    Potentiostats
    Software for Biosensor Data Analysis
    Spectroscopic Transduction
    Fourier Transform Infrared Spectroscopy
    Spectrophotometers for Sensor Applications
    Infrared Reflectance Probes
o    High-Tech Biosensors
    Miniaturization of Sensors
    Nanoparticle Sensors
    Quantum Dots
    Representative Current High-Tech Biosensor Development Projects
    Smart Sensors
o    Biochemical Recognition
    Enzyme Biocatalysts-Based Biosensors
    Enzyme Inhibition
    Bioaffinity-Based Biosensors
    Immunosensors
    Microorganism-Based Biosensors
    Oxygen Demand and Inhibition
    Genetically Engineered Microorganisms
o    Signal Transduction
    Potentiometric Transducers
    Amperometric Transducers
    Conductance Measurements
    Optical Measurements
    Fluorescence
    Protein Chip System
    Surface Plasmon Resonance
    Electrochemical Surface Plasmon Resonance (E-SPR)
    SPR Biosensor: Tool for Real-time Analysis of Biomolecular Interactions
    Sensitive Optical Detection
o    Sensors Based on the Piezoelectric Effect
    Introduction
o    Acoustic Transducers
    Surface Phenomena of Piezoelectric Materials
o    Sensor Manufacturing Technologies
    Microfluidics and LOC Technologies
    Microelectronic Manufacturing Technologies
    Monolithic Semiconductor Technologies
    Lithography
    Ceramic-Based Sensors
    Polycrystalline and Vitreous Systems
    Thin- and Thick-film Technologies
    Evaporation and Sputtering
    Processing Polymer Films
    Photolithography
    Electrically Active Polymers
    Fiberoptic Technologies

•    Chapter Four: Biosensor Applications
o    Biomedical Applications
    Special Requirements
    Medical Imaging
    Clinical Diagnosis
    Chemical and Biosensors for Clinical in Vivo Monitoring
    Point of Care Biosensor Applications
    Advances in Point-of-Care Testing
    Future POCT Innovations
    The Future of POCT
    Non-Clinical Diagnostics
    Molecular Diagnostics Clinical Tests and Clusters
    Nanoscale Devices and Nanotechnologies
    Nanotubes for Biological Sensors
o    Foodborne Microbial Pathogen Detection
    E. Coli O157:H7
    Liposome-Based Bacteria Sensors
    New Food Sensor Techniques
    New Detection Methods Improve Food Safety
    Monitoring Food for Residues
    Detection of Pathogens and Toxins in Food
    Detection of Listeria Pathogen
    Market Restraints on Food Diagnostics
o    Environmental Pollution and Hazard Monitoring
    Monitoring for Toxic Industrial Materials
    Future Directions
o    Biowarfare and Bioterrorism
    Bioterrorism Gets Our Attention
    Requirements For Sensing Biological Weapons
    Technologies for Bioagent Detection
    Biosensors for Chemical Agents
o    Industrial Process Control
    World Process Analytical Instrumentation Market
    Market Penetration into Nonmedical Applications
•    Chapter Five: The Biosensor Market
o    Market Dynamics and Factors Effecting the Overall Segment
    The Focus is on Development of Applications as well as Sensors
    High Costs of Biosensor Development
    Manufacturing and Product Problems
    Biosensor Development Specialists Work Closely with Users
    Technologies Synergistic with Biosensors are Maturing and Competing
    Impact of Miniaturization and Nanotechnology
    Rapid Development of Microarray Technology Encourages Investment
    Need to Balance Fundamental Research and Application Development
    Older Technologies are Difficult to Replace
    Small Companies with Niche Markets verses Large Companies with Mass Markets
o    Factors that are Expanding the Biosensor Market
    Greater Expectations of Quality of Life
    Innovative new Technologies and Applications
    Collaboration among Industrial, Governmental, and Academic Laboratories
    Growing Acceptance of Biosensor Methods
o    Successful Biosensors
o    Market Data

•    Chapter Six: Company Profiles
o    Abbott Diabetes Care
o    Abbott Laboratories
o    ABTECH Scientific, Inc.
o    Advanced Biosensor Inc.
o    Affinity Sensors
o    Affymetrix
o    Agilent Technologies
o    Akubio Ltd
o    Alcove Surfaces GmbH
o    Alnylam Pharmaceuticals
o    Ambri Limited
o    AMETEK Princeton Applied Research
o    Antibodies Incorporated
o    Applera Corporation
o    Applied BioPhysics, Inc.
o    Archemix Corp.
o    BCR Diagnostics Inc.
o    BD Biosciences
o    Beckman Coulter
o    Becton, Dickinson and Company
o    Biacore International AB
o    BioForce Nanosciences, Inc.
o    Biophage Pharma, Inc.
o    Biosite Incorporated
o    Boston MicroSystems
o    Bruker BioSciences Corporation
o    Chemel AB
o    Cholestech Corporation
o    Ciphergen Biosystems
o    CombiMatrix Corporation
o    Cranfield University -- Institute of BioScience and Technology
o    Cytoplex Biosciences
o    Dade Behring Holding Inc.
o    Diagnostic Products Corporation
o    Diversa Corporation
o    DuPont Microcircuit Materials
o    Endress+Hauser, Inc.
o    Ercon, Inc.
o    Evident Technologies
o    Farfield Sensors Ltd Unit 51
o    FIAlab Instruments, Inc
o    HTS Biosystems Incorporated
o    Human Genome Sciences
o    i-STAT Corporation,
o    Ibis Technology Corporation
o    Infineon Technologies AG
o    Invitrogen Corporation
o    Isis Pharmaceuticals, Inc.
o    Johns Hopkins University
o    Johnson & Johnson
o    Luna Analytics
o    Matsushita Electric Industrial Co., Ltd.
o    MicroFluidic Systems, Inc.
o    MicroTEC Gesellschaft f丒 Mikrotechnologie mbH
o    Mitsubishi Electric Corporation
o    Molecular Devices Corporation
o    Molecular Probes, Inc.
o    Nanotechnology Institute
o    Neogen Corporation
o    NeuroMetrix Inc.
o    Nitrate Elimination Co., Inc. (NECi)
o    Nomadics, Inc.
o    Nova Biomedical
o    PDSi Pinnacle
o    Perkin Elmer
o    Perlegen Sciences, Inc.
o    PharmaNetics, Inc
o    Prolinx, Inc.
o    Qiagen
o    QMED Inc.
o    QTL Biosystems, LLC QTL Biosystems (UK) Ltd.
o    Quantum Dot Corp.
o    Rapid Biosensor Systems Ltd
o    Reichert Analytical Instruments
o    Roche Holding Ltd.
o    Sensopath Technologies
o    Sixth Sense
o    Spacelabs Medical, Inc.
o    Spectral Diagnostics Inc.
o    SpectRx Inc.
o    SRU Biosystems, Inc.
o    Strategic Diagnostics Inc.
o    Tetracore, Inc
o    Thermo Electron Corporation
o    Thermotron Industries
o    Theron, Inc.
o    ThreeFold Sensors
o    Toshiba Medical Systems
o    Transducer Technology, Inc.
o    USAID Development Experience Clearinghouse
o    XanTec bioanalytics GmbH
o    Zyomyx, Inc.

•    Appendix A: Annotated List of Potentiostat
•    Manufacturers and Distributors
•    Appendix B: Ancillary Data Used to Support Market Assumptions
•    Appendix C: Selected Recent U.S. Patents on Biosensors
o    List of Exhibits
•    Chapter one: Executive Summary
o    Exhibit 1: Summary: World Market for Biosensors 2004-2009
•    Chapter two: Introduction
o    Exhibit 2: Summary of Common General Biosensor Applications
o    Exhibit 3: General Classification of Technologies Used in the Design of Biosensors
o    Exhibit 4: List of Specific Biosensor Applications
o    Exhibit 5: Sensors Commonly Classified According to the Quantity That They Measure
o    Exhibit 6: Important Applications of Biosensors
o    Exhibit 7: General Types of Analyte-Bioreceptor Interactions
o    Exhibit 8: Biochemical Recognition Molecules--Receptors
o    Exhibit 9: Common Transducer Technologies Used in Biosensors Systems
•    Chapter Three: Biosensor Technology
o    Exhibit 10: Commercialization Challenges for General Biosensors
o    Exhibit 11: Summary of Selected Commercial Flow Analyzers (Manufacturer, Price, Applications, Flow Diameter/Sample Throughput, Sample Injection/Number/Volume, Detectors, Accessories)
o    Exhibit 12: Examples of Sensor Functions Facilitated by Microprocessor and Memory Built into a Smart Sensor
o    Exhibit 13: Some Examples of Biomolecular Interactions Which Have Been Successfully Studied Using SPR
o    Exhibit 14: Classical Materials and Processing Technologies Used to Fabricate Biosensors
o    Exhibit 15: Advantages and Disadvantages of Silicon-Based Sensor Production (Monolithic Semiconductor Processing)
o    Exhibit 16: Advantages of Applying Thin and Thick Films in Sensor Fabrication
o    Exhibit 17: Advantages and Disadvantages of Applying Polymer Films in Sensors
o    Exhibit 18: Some Advantages and Disadvantages of Fiberoptic
•    Chapter Four: Biosensor Applications
o    Exhibit 19: Number of Foodborne Disease Outbreaks and Cases by Etiology 2003 Summary Statistics
o    Exhibit 20: Obstacles Common to All Commercially Viable Biosensors Used for Field Analytical Methods
o    Exhibit 21: Important Factors in the Selection of Biosensors for Process Control Analyzers
•    Chapter Five: The Biosensor Market
o    Exhibit 22: World Biosensor Market by Geographical Region/Country (North America, European Union, Japan, China, Latin America, India, Eastern Europe, Rest of World) 2004-2009
o    Exhibit 23: World Biosensor Market by General Application (Research Laboratories, Medical Applications, Industrial Control, Biodefense, Environmental) 2004-2009
o    Exhibit 24: The World Market for Biosensors for Medical Measurement Applications by Application (Blood Glucose, Coagulation Rate, Cholesterol, Others) 2004-2009
o    Exhibit 25: The World Market for Biosensors for Industrial Process Control by Type (Alcohol/Beverages/Fuel, Sugars/Carbohydrates, Dairy Products, Meat Products, Others) 2004-2009
•    Appendix B: Ancillary Data Used to Support Market Assumptions
o    Exhibit B-1: World Healthcare Expenditure (Government and Private) by Region, 2004-2009
o    Exhibit B-2: World Markets for Bioanalytical Equipment by Type (Total Biohazard Diagnostics, Biochip Systems [LOC, Arrays], Protein Microarrays, and Total Analytical Microarrays), 2004-2009
o    Exhibit B-3: Number of Biotech Companies by Region (North America, Europe, Asia/Pacific, Rest of World) 2004-2009

不能给全文，可惜了